Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do we need full compliance data for population pharmacokinetic analysis?

P Girard1, L B Sheiner, H Kastrissios

  • 1Department of Pharmacy, School of Pharmacy, University of California, San Francisco, USA.

Journal of Pharmacokinetics and Biopharmaceutics
|June 1, 1996
PubMed
Summary

Accurate electronic monitoring of drug intake is crucial for population pharmacokinetic analysis. New strategies using this data improve parameter estimation and reduce computational time.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacodynamic measurements of methyl nicotinate percutaneous absorption.

Pharmaceutical research·2013
Same author

A new Bayesian method to forecast and fine tune individual hemodialysis dose.

Hemodialysis international. International Symposium on Home Hemodialysis·2009
Same author

Predictive population pharmacokinetic/pharmacodynamic model for a novel COX-2 inhibitor.

Journal of clinical pharmacology·2007
Same author

Thoracoscopic palliative treatment of malignant pleural effusions: results in 273 patients.

Surgical endoscopy·2006
Same author

Development of a predictive pharmacokinetic model for a novel cyclooxygenase-2 inhibitor.

Journal of clinical pharmacology·2006
Same author

[Diagnostic approach to venous thromboembolic disease].

Presse medicale (Paris, France : 1983)·2005

Area of Science:

  • Pharmacokinetics
  • Pharmacometrics
  • Drug Development

Background:

  • Accurate dose input is critical for population pharmacokinetic (PopPK) analysis.
  • Electronic monitoring devices provide precise drug-taking behavior data for ambulatory patients.
  • Traditional PopPK methods often ignore detailed dosing information, leading to biased parameter estimates.

Purpose of the Study:

  • To investigate optimal strategies for utilizing and summarizing electronic monitoring data in PopPK analysis.
  • To develop a Markov chain process model for simulating compliance data.
  • To evaluate the impact of dosing information on PopPK parameter estimation.

Main Methods:

  • Development of a Markov chain process model to simulate patient compliance data.

Related Experiment Videos

  • Simulation and analysis of data from electronically monitored patients.
  • Iterative estimation of PopPK parameters using summarized dosing information.

    • Main Results:

    • Ignoring actual dosing information leads to biased clearance and volume estimates and overestimates interindividual variability.
    • A three-step summarization strategy using limited dose records and iterative parameter estimation is proposed.
    • This strategy achieves parameter estimates comparable to using full dosing records but reduces computational time by over 75%.

    Conclusions:

    • Electronic monitoring data significantly improves the accuracy of PopPK analyses.
    • The proposed data summarization strategy offers an efficient method for incorporating precise dosing information.
    • Optimized PopPK analysis using electronic monitoring data enhances drug development and clinical trial efficiency.